Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 21, 2017

Study Completion Date

May 16, 2017

Conditions
Neuromuscular BlockadePulmonary Complication
Interventions
DEVICE

Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology

Quantitative train-of-four (TOF) ratio will be recorded in the post anesthesia care unit (PACU) via Stimpod NMS450

Trial Locations (1)

43228

OhioHealth Doctors Hospital, Columbus

Sponsors

Lead Sponsor

All Listed Sponsors
lead

OhioHealth

OTHER

NCT02984839 - Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study | Biotech Hunter | Biotech Hunter